FLAVIVACCINE is an innovation project co-funded by the European Union to develop a single vaccine candidate against multiple flaviviruses, including Dengue, Yellow Fever, Zika, and West Nile. The project began in January 2024 and will run until December 2027.

FLAVIVACCINE aims to enhance the EU’s preparedness and response to future epidemic and pandemic threats by delivering a safe and effective vaccine.

In the first issue:

• FLAVIVACCINE General Assembly in Madrid: A key event for discussing research advancements, dissemination activities, and strategic planning.
• One scientific paper co-authored by FLAVIVACCINE coordinator Julien Pompon, exploring how West Nile virus can spread through mosquito excreta.
• One scientific paper about challenges, effectiveness, safety, and the pros and cons of various administration routes, such as intramuscular, transdermal, oral, and nasal delivery.
• The FLAVIVACCINE presentation video and the project flyer.

We hope you enjoy our newsletter. To dive deeper into it, READ HERE.

Best regards,
The FLAVIVACCINE Team

Stay informed with the latest advancements, subscribing our newsletter

Foto di Mariia Shalabaieva su Unsplash